Market revenue in 2023 | USD 58.1 million |
Market revenue in 2030 | USD 77.9 million |
Growth rate | 4.3% (CAGR from 2023 to 2030) |
Largest segment | Malignant tumors |
Fastest growing segment | Functional Disorders |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Malignant Tumors, Benign Tumors, Vascular Disorders, Functional Disorders, Ocular Diseases |
Key market players worldwide | Elekta AB ADR, Varian, Akesis Pharmaceuticals, Huiheng Industry |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to gamma knife market will help companies and investors design strategic landscapes.
Malignant tumors was the largest segment with a revenue share of 45.44% in 2023. Horizon Databook has segmented the China gamma knife market based on malignant tumors, benign tumors, vascular disorders, functional disorders, ocular diseases covering the revenue growth of each sub-segment from 2018 to 2030.
Rise in healthcare expenditure, emergence of market players, and upgrading existing gamma knife systems to advanced gamma knife technologies are key factors expected to positively impact the market over the forecast period. Gamma Knife Icon received China FDA clearance in February 2018.
In China, more than 100,000 cases of brain cancer are diagnosed every year. This represents a high demand for advanced radiotherapy. The country is home to two key emerging players, MASEP Medical Science Technology Development Co., Ltd. And Huiheng Group Co., Ltd.
These companies offer state-of-the-art gamma knife radiotherapy systems, namely, Intracranial SRRS and Super Gamma Ray Treatment System (SGS-I type), respectively. China held the largest market share of 33.9% in Asian Pacific’s market in 2020. Interventional clinical studies are being undertaken in this country to increase treatment scope, which is expected to drive the market.
Horizon Databook provides a detailed overview of country-level data and insights on the China gamma knife market , including forecasts for subscribers. This country databook contains high-level insights into China gamma knife market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account